Bioremediation of Acetaminophen Mediated by Klebsiella pneumoniae subsp. pneumoniae DSM 30104 (T)

IJEP 43(7): 579-587 : Vol. 43 Issue. 7 (July 2023)

Meghmala Waghmode1, Neha Patil1* and Aparna Gunjal2

1. PDEA’s Annasaheb Magar Mahavidyalaya, Department of Microbiology, Pune, Maharashtra – 411 028, India
2. Dr. D. Y. Patil Arts, Commerce and Science College, Department of Microbiology, Pune, Maharashtra – 411 018, India

Abstract

Acetaminophen is one of the widely used over-the-counter drugs. Its residual concentration has been detected in pharmaceutical industry wastewater, effluent treatment plant and surface water. Eco-toxicological effects of paracetamol have been reported on seed germination, fish and algae. Drug resistance in pathogenic micro-organisms has been attributed to the overuse or continuous exposure of pathogens to drugs. The work was conducted from February 2022 to July 2022. Current study was carried out on the acetaminophen (paracetamol) degradation potential of Klebsiella pneumoniae subsp. pneumoniae DSM 30104(T) which was isolated from effluent of pharma industry. Identification was done using 16S rRNA sequencing technique. Isolate was found to degrade 82.8% of acetaminophen (2500 ppm) after five days of incubation. Based on the analytical techniques high resolution mass spectrometry (HRMS) and proton nuclear magnetic spectroscopy (1H NMR) study, 4-aminophenol was found to be biodegradative metabolite. Klebsiella pneumoniae subsp. pneumoniae DSM 30104(T) can degrade paracetamol through biological approach. Compared to paracetamol, its biodegradative product 4-aminophenol has more toxicity against algae. The paracetamol biodegradation potential of Klebsiella pneumoniae subsp. pneumoniae DSM 30104(T) was studied and could be used as microbial candidate for remediation of paracetamol contaminated sites.

Keywords

Acetaminophen, Biodegradation, Pathogens, Phyloge-netics, Wastewater

References

  1. Dixit, D. and N. Parmar. 2013. Treatment of pharmaceutical wastewater by electro-coagulation and natural coagulation process: Review. VSRD Int. J. Technical Non-Technical Res., 4(5): 79-88.
  2. Barbosa, M., et al. 2016. Occurrence and removal of organic micro pollutants: An overview of the watch list of EU decision 2015/495. Water Res., 94: 257-279.
  3. Vymazal, J., et al. 2017. Occurrance and removal of pharmaceutical in four full-scale constructed wetlands in the Czecb Republic – The first year of monitoring. Ecol. Eng., 98 : 354-364.
  4. Philip, J.M., U.K. Aravind and C.T. Aravindakumar. 2018. Emerging contaminants in Indian environmental matrices – A review. Chemosphere. 190: 307-326.
  5. Singh, V. and S. Suthar. 2021. Occurrence, seasonal variations and ecological risk of pharmaceuticals and personal care products in river Ganges at two holy cities of India. Chemosphere. 268: 129331.
  6. Rabiet, M., et al. 2006. Consequence of treated water recycling as regards pharmaceuticals and drugs in surace and groundwaters of a medium-sized Mediterranean catchment. Env. Sci. Tech., 40: 5282-5288.
  7. Galani, A., et al. 2021. Patterns of pharmaceuticals use during the first wave of Covid-19 pandemic in Athens, Greece as revealed by wastewater-based epidemiology. Sci. Total Env., 798: 149014.
  8. Caracciolo, A., E. Topp and P. Grenni. 2014. Pharmaceuticals in the environment: Biodegradation and effects on natural microbial communities : A review. J. Pharmaceutical Biomedical Analysis. 106(2015) : 25-36.
  9. Pendleton, J.N., S.P. Gorman and B.F. Gilmore. 2013. Clinical relevance of the ESKAPE pathogens. Expert Review Anti-Infective Therapy. 11(3): 297-308.
  10. Piedade, F., S. Bio and B. Nunes. 2020. Effects of common pharmaceutical drugs (paracetamol and acetylsalicylic acid) short term exposure on biomarkers of the mussel Mytilus spp. Env. Toxicol. Pharmacol., 73: 103276.
  11. Fatima, S., et al. 2020. Toxicity of NSAID drug (paracetamol) to non-target organism – Nostoc muscorum. Env. Sci. Poll. Res., 27(28): 35208-35216.
  12. Badar, Z., et al. 2022. Assessment of uptake, accumulation and degradation of paracetamol in spinach (Spinacia oleracea L.) under controlled laboratory conditions. Plants. 11(13):1626.
  13. Kummerová, M., et al. 2016. Possible ecological risk of two pharmaceuticals diclofenac and paracetamol demonstrated on a model plant Lemna minor. J. hazard. mater., 302: 351-361.
  14. Rede, D., et al. 2019. Individual and mixture toxicity evaluation of three pharmaceuticals to the germination and growth of Lactuca sativa seeds. Sci. total env., 673:102-109.
  15. Chopra, S. and D. Kumar. 2020. Characterization, optimization and kinetics study of acetaminophen degradation by Bacillus drentensis strain S1 and wastewater degradation analysis. Bioresour. Bioprocessing. 7(1): 1-18.
  16. Ebele, A., M. Abdallah and S. Harrad. 2017. Pharmaceuticals and personal care products (PPCPs) in the freshwater aquatic environment. Emerging Contam., 3(1): 1-16.
  17. Edrees, W.H.A., et al. 2017. A review on comparative study between the physico-chemical and biological processes for paracetamol degradation. Universal J. Pharmaceutical Res., 2(2): 32-41.
  18. Ivshina, I., et al. 2006. Catalysis of the biodegradation of unusable medicines by Alkanotrophic rhodococci. Prikladnaia Biokhimiiai Mikrobiol., 42(4): 443-447. doi:10.1134/S0003683806040090.
  19. Zhang, L., et al. 2013. Degradation of paracetamol by pure bacterial cultures and their microbial consortium. Appl. microbiol. biotech., 97(8): 3687-3698.
  20. Bart, D.G., et al. 2011. Degradation of acetaminophen by Delftia tsuruhatensis and Pseudomonas aeruginosa in a membrane bioreactor. Water Res., 45:1829–1837.
  21. Kumari, T.R., et al. 2009. biotransformation of paracetamol by Cunninghamella echinulata. J. Pharmaceutical Res., 8(1) : 1-5.
  22. Chen, R., X. Liu and Y. Ma. 2022. Isolation and identification of acetaminophen degrading strain Shinella sp. HZA2. J. Env. Sci. Health Part B. 57(5): 333-338.
  23. Dos Grignet, S., et al. 2022. Medicines as an emergent contaminant: the review of microbial biodegration potential. Folia Microbiol., 67(2): 157-174.
  24. Lee, S., et al. 2015. Crystal structure analysis of a bacterial aryl acylamidase belonging to the amidase signature enzyme family. Biochem. Biophysical Res. Commun., 467(2): 268-274.
  25. Zur, J., et al. 2018b. Paracetamol toxicity and microbial utilization. Pseudomonas moorei KB4 as a case study for exploring degradation pathway. Chemosphere. 206: 192-202.
  26. Rios-Miguel, A.B., et al. 2022. Microbial para-cetamol degradation involves a high diversity of novel amidase enzyme candidates. Water Res. X. 16:100152.
  27. Alajmi, H.M. 2014. Effect of physical, chemical and biological treatment on the removal of five pharmaceuticals from domestic wastewater in laboratory-scale reactors and full-scale plant. Doctoral dissertation. Newcastle University.
  28. Roberts, P.H. and K.V. Thomas. 2006. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Env., 356(1-3): 143-153.
  29. Mutiyar, P.K., S.K. Gupta and A.K. Mittal. 2018. Fate of pharmaceutical active compounds (PhACs) from river Yamuna, India: An eco-toxicological risk assessment approach. Ecotoxicol. Env. Safety. 150: 297-304.
  30. Subedi, B., et al. 2017. Mass loading and removal of pharmaceuticals and personal care products including psychoactive, antihypertensive and antibiotics in two sewage treatment plants in Southern India. Chemosphere. 167: 429-437.
  31. Archana, G., R. Dhodapkar and A. Kumar. 2016. Offline solid-phase extraction for pre-concentration of pharmaceuticals and personal care products in environmental water and their simultaneous determination using the reversed phase high-performance liquid chromatography method. Env. monit. assess., 188(9):1-10.
  32. Fram, M.S. and K. Belitz. 2011. Occurrence and concentrations of pharmaceutical compounds in groundwater used for public drinking water supply in California. Sci. Total Env., 409(18): 3409-3417.
  33. Scott, P.D., et al. 2014. A national survey of trace organic contaminants in Australian rivers. J. env. quality. 43(5):1702-1712.
  34. K’oreje, K.O., et al. 2012. From multi-residue screening to target analysis of pharmaceuticals in water: Development of a new approach based on magnetic sector mass spectrometry and application in the Nairobi river basin, Kenya. Sci. Total Env., 437: 153-164.
  35. Matongo, S., et al. 2015. Pharmaceutical residues in water and sediment of Msunduzi river, Kwazulu-natal, South Africa. Chemosphere. 134: 133-140.
  36. Wiegel, S., et al. 2004. Pharmaceuticals in the river Elbe and its tributaries. Chemosphere. 57(2):107-126.
  37. Ternes, T.A. 1998. Occurrence of drugs in German sewage treatment plants and rivers. Water res., 32(11): 3245-3260.
  38. Kolpin, D., et al. 2002. Pharmaceuticals, hormones and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Env. Sci. Tech., 36(6): 1202-1211.
  39. Grujic, S., T. Vasiljevic and M. Lausevic. 2009. Determination of multiple pharmaceutical classes in surface and ground waters by liquid chromatography-ion trap-tandem mass spectrometry. J. Chromatography A. 1216(25) : 4989-5000.
  40. Sambrook, H.C. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor, New York.
  41. Yoon, S.H., et al. 2017. Introducing EzBioCloud: A taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies. Int. j. systematic Evolutionary microbiol., 67(5): 1613.
  42. Stone, K.M., F.W. Roche and N.F. Thornhill. 1992. Dry weight measurement of microbial biomass and measurement variability analysis. Biotech. techniques., 6(3): 207-212.
  43. Sane, R. and S. Kamat. 1980. Simple colourimetric method for determination of acetaminophen. J. AOAC Int., 63(6): 1189-1190.
  44. Zhang, H., et al. 2012. Oxidative removal of acetaminophen using zero valent aluminum-acid system: Efficacy, influencing factors and reaction mechanism. J. Env. Sci., 24: 314-319.
  45. Nichols, H.W. and H.C. Bold. 1965. Trichosarcina polymorpha gen. et sp. nov. J. phycol., 1(1): 34-38.
  46. Wang, D.C.Y., W.L. Chu and Y.Y. Kok. 2015. Assessment of paracetamol (acetaminophen) toxicity in microalgae. Polish J. Env. Studies. 24(2): 735-741.
  47. AAT Bioquest, Inc. 2022. Quest Graph™ IC50 calculator. AAT Bioquest. Available at: https://www. aatbio.com/tools/ic50-calculator.
  48. Saitou, N. and M. Nei. 1987. The neighbour-joining method: A new method for reconstructing phylogenetic trees. Molecular biol. evol., 4(4): 406-425.
  49. Felsenstein, J. 1985. Confidence limits on phylogenies: An approach using the bootstrap. Evolution. 39:783- 791.
  50. Tamura, K., et al. 2013. MEGA6: Molecular evolutionary genetics analysis version 6.0. Molecular biol. evol., 30(12): 2725-2729.
  51. Palma, T.L., G. Magno and M.C. Costa. 2021. Biodegradation of paracetamol by some Gram-positive bacterial isolates. Curr. Microbiol., 78: 2774-2786.
  52. Palma, T.L., et al. 2018. Putative role of Flavobacterium, Dokdonella and Methylophilus strains in paracetamol biodegradation. Water Air Soil Poll., 229(6):1-23.
  53. De Gusseme, B., et al. 2011. Degradation of acetaminophen by Delftia tsuruhatensis and Pseudomonas aeruginosa in a membrane bioreactor. Water Res., 45(4): 1829-1837.
  54. Ahmed, S., et al. 2001. Isolation and characterization of a Pseudomonas strain that degrades 4-acetamidophenol and 4-aminophenol. Biodegrad., 12(5) : 303-309.
  55. Hu, J., et al. 2013. Degradation of paracetamol by Pseudomonas aeruginosa strain HJ1012. J. Env. Sci. Health Part A. 48(7): 791-799.
  56. Larsson, D., C. Pedro and N. Paxeus. 2007. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J. Hazard. Mater., 148(3): 751-755.
  57. Lenz, D., et al. 2007. Nerve agent bioscavengers: Progress in development of a new mode of protection against organophosphorus exposure. In Chemical welfare agents: Chemistry, pharmacology, toxicology and therapeutics. Ed. J. Romaro, B. Luckey and H. Salem. CRC Press, Boca Raton, Florida. pp 175-202.
  58. Asimakopoulos, G. and K. Kannan. 2016. Neuropsychiatric pharmaceuticals and illicit drugs in wastewater treatment plants: A review. Env. Chem.,13: 541-576.
  59. Yakubu, H., 2017. Pharmaceutical wastewater effluent – Source of contaminants of emerging concern: Phytotoxicity of metronidazole to soybean (Glycine max). Toxics. 5(2). doi:10.3390/toxics 5020010.
  60. Podschun, R. and U. Ullmann. 1998. Klebsiella sp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods and pathogenicity factors. Clinical microbiol. reviews. 11(4): 589-603.
  61. Falade, A.G. and A.I. Ayede. 2011. Epidemiology, aetiology and management of childhood acute community-acquired pneumonia in developing countries- A review. African j. medicine medical Sci., 40(4): 293-308.
  62. Jones, R.N. 2010. Microbial aetiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clinical infectious diseases. 51(Supplement_1): S81-S87.
  63. Kumar, P., et al. 2021. Characterization of arsenic-resistant Klebsiella pneumoniae RnASA11 from contaminated soil and water samples and its bioremediation potential. Current Microbiol., 78(8): 3258-3267.
  64. Aransiola, E.F., et al. 2017. Heavy metals biore-mediation potential of Klebsiella sp. isolated from diesel polluted soil. African J. Biotech., 16(19): 1098-1105.
  65. Padhi, S.K., et al. 2013. Characterisation of heterotrophic nitrifying and aerobic denitrifying Klebsiella pneumoniae CF-S9 strain for bioremediation of wastewater. Int. Biodeterioration Biodegrad., 78: 67-73.
  66. Sharma, S., H. Setia and A.P. Toor. 2021. Assessing the bioremediation potential of indigenously isolated Klebsiella sp. WAH1 for diclofenac sodium: Optimization, toxicity and metabolic pathway studies. World J. Microbiol. Biotech., 37(2):1-12.